On Invalid Date, Astrazeneca (NASDAQ: AZN) reported Q3 2022 earnings per share (EPS) of $0.53, up 196.36% year over year. Total Astrazeneca earnings for the quarter were $1.64 billion. In the same quarter last year, Astrazeneca's earnings per share (EPS) was -$0.55.
As of Q1 2023, Astrazeneca's earnings has grown -13.95% year over year. This is 53.44 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.48%. Astrazeneca's earnings in the past year totalled $2.04 billion.
What is AZN's earnings date?
Astrazeneca's earnings date is Invalid Date. Add AZN to your watchlist to be reminded of AZN's next earnings announcement.
What was AZN's revenue last quarter?
On Invalid Date, Astrazeneca (NASDAQ: AZN) reported Q3 2022 revenue of $10.98 billion up 11.31% year over year. In the same quarter last year, Astrazeneca's revenue was $9.87 billion.
What was AZN's revenue growth in the past year?
As of Q1 2023, Astrazeneca's revenue has grown 37.6% year over year. This is 25.26 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 12.34%. Astrazeneca's revenue in the past year totalled $45.15 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.